Insider · CIK 0001918615

Landau Jeffrey B

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001918615

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-20	CTMXCytomX Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−4,181 sh	$1.23	−$5,138.867	119,056
2024-08-20	CTMXCytomX Therapeutics, Inc. · Performance Stock Units (PSUs)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−11.3K sh	—	—	0
2024-08-20	CTMXCytomX Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+11.3K sh	—	—	123,237
2024-03-19	CTMXCytomX Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−6,562 sh	$2.09	−$13.7K	110,060
2024-01-18	CTMXCytomX Therapeutics, Inc.A Award	Chief Business Officer	AAward	+30K sh	—	—	116,622
2024-01-18	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+140K sh	—	—	140,000
2024-01-18	CTMXCytomX Therapeutics, Inc. · Performance Stock Units (PSUs)A Award	Chief Business Officer	AAward	+75K sh	—	—	75,000
2023-12-20	CTMXCytomX Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−4,077 sh	$1.38	−$5,628.299	86,622
2023-12-17	CTMXCytomX Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+11.3K sh	—	—	90,699
2023-12-17	CTMXCytomX Therapeutics, Inc. · Performance Stock Units (PSUs)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−11.3K sh	—	—	11,250
2023-09-22	CTMXCytomX Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−4,119 sh	$1.30	−$5,355.936	76,379
2023-09-20	CTMXCytomX Therapeutics, Inc.A Award	Chief Business Officer	AAward	+11.3K sh	—	—	80,498
2023-03-16	CTMXCytomX Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−1,477 sh	$1.98	−$2,923.278	69,248
2023-02-02	CTMXCytomX Therapeutics, Inc.A Award	Chief Business Officer	AAward	+40K sh	—	—	70,725
2023-02-02	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+100K sh	—	—	100,000
2023-02-02	CTMXCytomX Therapeutics, Inc. · Performance Stock Units (PSUs)A Award	Chief Business Officer	AAward	+75K sh	—	—	75,000
2022-08-10	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+135K sh	—	—	135,000
2022-08-10	CTMXCytomX Therapeutics, Inc. · Performance Stock Units (PSUs)A Award	Chief Business Officer	AAward	+22.5K sh	—	—	22,500
2022-07-20	CTMXCytomX Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−4,206 sh	$1.42	−$5,981.773	30,725
2022-07-19	CTMXCytomX Therapeutics, Inc.A Award	Chief Business Officer	AAward	+11.3K sh	—	—	34,931

Recent filings

Accepted (ET)
Aug 224
Landau Jeffrey B0001610717-24-000436
SEC(opens sec.gov)
Mar 214
Landau Jeffrey B0001610717-24-000175
SEC(opens sec.gov)
Jan 194
Landau Jeffrey B0001610717-24-000033
SEC(opens sec.gov)
Dec 224
Landau Jeffrey B0001610717-23-000421
SEC(opens sec.gov)
Dec 194
Landau Jeffrey B0001610717-23-000410
SEC(opens sec.gov)
Sep 224
Landau Jeffrey B0001610717-23-000298
SEC(opens sec.gov)
Mar 204
Landau Jeffrey B0001140361-23-012615
SEC(opens sec.gov)
Feb 64
Landau Jeffrey B0001567619-23-001929
SEC(opens sec.gov)
Aug 124
Landau Jeffrey B0001567619-22-015866
SEC(opens sec.gov)
Jul 214
Landau Jeffrey B0001567619-22-014300
SEC(opens sec.gov)

Companies

CytomX Therapeutics, Inc.Chief Business OfficerCTMX

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080